SAN JOSE, Calif.--(BUSINESS WIRE)--Nov. 7, 2018--
Xperi Corporation (Nasdaq: XPER) (the “Company” or “we”) today announced
financial results for the third quarter ended September 30, 2018.
“During the third quarter, we delivered billings in line with our
expectations and managed operating expenses below the low end of our
range, resulting in better-than-expected profitability. In product
licensing, we announced a significant strategic partnership with IMAX
that significantly enhances our content ecosystem supporting growth
opportunities in the home and mobile markets,” said Jon Kirchner, chief
executive officer of Xperi. “On the Semiconductor and IP licensing side,
interest in our hybrid bonding solutions is accelerating and we have now
engaged multiple partners in evaluations of our DBI technology for
memory applications including stacked DRAM and 3D NAND. We believe this
technology is going to be widely deployed by the memory industry over
the long term.”
Financial Highlights
($ and share count in thousands)
|
|
GAAP |
|
|
Non-GAAP |
|
|
|
Q3 2018 |
|
Q3 2017 |
|
|
Q3 2018 |
|
Q3 2017 |
|
Billings 1
|
|
$
|
100,587
|
|
$
|
85,308
|
|
|
$
|
100,587
|
|
$
|
85,308
|
|
Total Operating Expense 2
|
|
$
|
92,126
|
|
$
|
98,434
|
|
|
$
|
57,465
|
|
$
|
58,642
|
|
Interest Expense 1
|
|
$
|
6,343
|
|
$
|
7,371
|
|
|
$
|
6,343
|
|
$
|
7,371
|
|
Other Income / (Expense) 2
|
|
$
|
1,737
|
|
$
|
739
|
|
|
$
|
160
|
|
$
|
739
|
|
Cash Tax Payments 1
|
|
$
|
4,462
|
|
$
|
4,405
|
|
|
$
|
4,462
|
|
$
|
4,405
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted Shares Outstanding
|
|
48,958
|
|
49,469
|
|
|
51,776
|
|
52,794
|
| 1 |
|
Measures are the same for both the GAAP and Non-GAAP presentation.
|
| 2 |
|
See tables for reconciliations.
|
|
|
|
| Other Relevant Metrics |
|
Q3 2018 |
|
Q3 2017 |
|
Operating Cash Flow 1 |
|
$
|
29,398
|
|
$
|
39,967
|
|
Cash, Cash Equivalents, S-T Investments and Restricted Cash
|
|
$
|
105,435
|
|
$
|
157,300
|
| 1 |
|
Q3 2017 operating cash flow includes receipt of a late customer
payment of approximately $11 million that should have been received
in Q2 2017. Q3 2018 operating cash flow was impacted by
approximately $6 million in billings invoiced late in Q3, most of
which has already been collected in Q4.
|
|
|
|
Stock Repurchase Program
During the third quarter of 2018, the Company repurchased approximately
461 thousand shares of common stock for an aggregate amount of $7.2
million. These purchases were executed under the Company's stock
repurchase program. As of September 30, 2018, the Company had
approximately $106 million remaining under its current repurchase
program.
Dividends
On September 6, 2018, the Company paid $9.8 million to stockholders of
record on August 16, 2018, for the quarterly cash dividend of $0.20 per
share of common stock.
Additionally, on October 25, 2018, the Board of Directors approved the
quarterly dividend of $0.20 per share of common stock, payable on
December 19, 2018, to stockholders of record on November 28, 2018.
Financial Guidance
Consequent with the introduction of the new revenue accounting standard,
ASC 606, the Company announced it would begin using billings as a key
measure of business progress. As a result, the Company’s outlook is now
based on billings rather than GAAP revenue. For additional information
regarding the Company’s approach to guidance, please review the “ASC 606
Business Metrics and Guidance Approach” presentation given by the
Company on January 25, 2018, at http://investor.xperi.com/events.cfm.
|
|
|
|
|
|
|
|
Q4 2018
|
|
|
GAAP Outlook
|
|
|
Non-GAAP Outlook
|
|
Billings 1
|
|
|
$109M to 124M
|
|
|
$109M to 124M
|
|
Operating Expense
|
|
|
$95M to 99M
|
|
|
$59M to 63M
|
| 1 |
|
Measures are the same for both the GAAP and Non-GAAP presentation.
|
|
|
|
The Company is lowering the high end of its fiscal year 2018 billings
range to reflect greater visibility at this point in the year and
updated timing and risk adjustments associated with the Semiconductor
and IP Licensing forecast. The Company is also reducing its operating
expense outlook for the year and adjusting down its diluted share count
due to buybacks. Additionally, the Company is updating its operating
cash flow outlook to reflect changes in billings and expenses, and
balance sheet movements.
The revised 2018 outlook is as follows:
|
|
|
|
|
|
|
|
FY 2018
|
|
|
GAAP Outlook
|
|
|
Non-GAAP Outlook
|
|
Billings 1
|
|
|
$415M to 430M
|
|
|
$415M to 430M
|
|
Operating Expense
|
|
|
$377M to 381M
|
|
|
$235M to 239M
|
|
Cash Tax Payments 1
|
|
|
$16M to 20M
|
|
|
$16M to 20M
|
|
Fully Diluted Shares
|
|
|
49.0M
|
|
|
52.0M
|
|
Operating Cash Flow 1
|
|
|
$120M to 130M
|
|
|
$120M to 130M
|
| 1 |
|
Measures are the same for both the GAAP and Non-GAAP presentation.
|
|
|
|
Conference Call Information
The Company will hold its third quarter 2018 earnings conference call at
2:00 PM Pacific Time (5:00 PM Eastern Time) on Wednesday, November 7,
2018. To access the call in the U.S., please dial 1-877-260-1479, and
for international callers dial +1 334-323-0522, approximately 15 minutes
prior to the start of the conference call. The conference ID is 5577657.
The conference call will also be broadcast live over the Internet at http://investor.xperi.com.
Safe Harbor Statement
This press release contains forward-looking statements, which are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements involve risks
and uncertainties that could cause actual results to differ
significantly from those projected, particularly with respect to the
Company’s financial results and guidance, the expected benefits of the
Company’s strategic partnership with IMAX, and the anticipated market
adoption of hybrid bonding solutions in the memory industry. Material
factors that may cause results to differ from the statements made
include the plans or operations relating to the businesses of the
Company; market or industry conditions; changes in patent laws,
regulation or enforcement, or other factors that might affect the
Company's ability to protect or realize the value of its intellectual
property; the expiration of license agreements and the cessation of
related royalty income; the failure, inability or refusal of licensees
to pay royalties; initiation, delays, setbacks or losses relating to the
Company's intellectual property or intellectual property litigations, or
invalidation or limitation of key patents; fluctuations in operating
results due to the timing of new license agreements and royalties, or
due to legal costs; the risk of a decline in demand for semiconductors
and products utilizing our audio and imaging technologies; failure by
the industry to use technologies covered by the Company's patents; the
expiration of the Company's patents; the Company's ability to
successfully complete and integrate acquisitions of businesses; the risk
of loss of, or decreases in production orders from, customers of
acquired businesses; financial and regulatory risks associated with the
international nature of the Company's businesses; failure of the
Company's products to achieve technological feasibility or
profitability; failure to successfully commercialize the Company's
products; changes in demand for the products of the Company's customers;
limited opportunities to license technologies due to high concentration
in applicable markets for such technologies; the impact of competing
technologies on the demand for the Company's technologies; pricing
trends, including the Company's ability to achieve economies of scale;
and other developments in the markets in which the Company operates, as
well as management's response to any of the aforementioned factors. You
are cautioned not to place undue reliance on the forward-looking
statements, which speak only as of the date of this release.
The foregoing review of important factors should not be construed as
exhaustive and should be read in conjunction with the other cautionary
statements that are included herein and elsewhere, including the Risk
Factors included in the Company's recent reports on Form 10-K and Form
10-Q and other documents of the Company on file with the Securities and
Exchange Commission (the "SEC"). The Company's SEC filings are available
publicly on the SEC's website at www.sec.gov.
Any forward-looking statements made or incorporated by reference herein
are qualified in their entirety by these cautionary statements, and
there can be no assurance that the actual results or developments
anticipated by the Company will be realized or, even if substantially
realized, that they will have the expected consequences to, or effects
on, the Company or its business or operations. Except to the extent
required by applicable law, the Company undertakes no obligation to
update publicly or revise any forward-looking statement, whether as a
result of new information, future developments or otherwise.
About Xperi Corporation
Xperi Corporation (Nasdaq: XPER) and its brands, DTS, FotoNation, HD
Radio, Invensas and Tessera, are dedicated to creating innovative
technology solutions that enable extraordinary experiences for people
around the world. Xperi’s solutions are licensed by hundreds of leading
global partners and have shipped in billions of products in areas
including premium audio, broadcast, automotive, computational imaging,
computer vision, mobile computing and communications, memory, data
storage, and 3D semiconductor interconnect and packaging. For more
information, please call +1 408-321-6000 or visit www.xperi.com.
Xperi, DTS, Invensas, FotoNation, HD Radio, Tessera and their respective
logos are trademarks or registered trademarks of affiliated companies of
Xperi Corporation in the United States and other countries. All other
company, brand and product names may be trademarks or registered
trademarks of their respective companies.
Billings
Billings reflect amounts in an accounting period invoiced to customers,
less any credits issued to or paid to customers, plus amounts due under
certain licensing-related contractual arrangements that may not be
subject to an invoice. Management evaluates the Company’s financial
performance in part based on billings due to the close alignment between
billings and cash receipts from licensing activity, and believes
billings is an important metric to provide to readers of our financial
results. Billings may vary materially from revenue recorded under U.S.
GAAP.
Non-GAAP Financial Measures
In addition to disclosing financial results calculated in accordance
with U.S. Generally Accepted Accounting Principles (GAAP), the Company’s
earnings release contains non-GAAP financial measures adjusted for
either one-time or ongoing non-cash acquired intangibles amortization
charges, acquired in-process research and development, all forms of
stock-based compensation, restructuring and other related exit costs.
Management believes that the non-GAAP measures used in this release
provide investors with important perspectives into the Company’s ongoing
business performance. The non-GAAP financial measures disclosed by the
Company should not be considered a substitute for, or superior to,
financial measures calculated in accordance with GAAP, and the financial
results calculated in accordance with GAAP and reconciliations to those
financial statements should be carefully evaluated. The non-GAAP
financial measures used by the Company may be calculated differently
from, and therefore may not be comparable to, similarly titled measures
used by other companies. All financial data is presented on a GAAP basis
except where the Company indicates its presentation is on a non-GAAP
basis.
Set forth below are reconciliations of the Company’s reported GAAP to
non-GAAP financial metrics.
XPER-E
|
|
| XPERI CORPORATION |
| FINANCIAL INFORMATION SCHEDULE |
|
COMPONENTS OF GAAP AND NON-GAAP OPERATING EXPENSE
|
| (in thousands) |
| (unaudited) |
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
September 30, |
|
|
|
|
2018 |
|
2017 |
|
GAAP operating expense - components
|
|
|
|
|
|
Cost of revenue
|
|
$
|
5,003
|
|
|
$
|
1,667
|
|
|
Research, development and other related costs
|
|
|
24,189
|
|
|
|
25,840
|
|
|
Selling, general and administrative
|
|
|
28,084
|
|
|
|
33,995
|
|
|
Amortization expense
|
|
|
27,208
|
|
|
|
27,769
|
|
|
Litigation expense
|
|
|
7,642
|
|
|
|
9,163
|
|
|
Total operating expenses
|
|
$
|
92,126
|
|
|
$
|
98,434
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
September 30, |
|
|
|
|
2018 |
|
2017 |
|
Non-GAAP operating expense - components
|
|
|
|
|
|
Cost of revenue
|
|
$
|
5,003
|
|
|
$
|
1,667
|
|
|
Research, development and other related costs
|
|
|
20,937
|
|
|
|
21,712
|
|
|
Selling, general and administrative
|
|
|
23,883
|
|
|
|
26,100
|
|
|
Litigation expense
|
|
|
7,642
|
|
|
|
9,163
|
|
|
Total operating expenses
|
|
$
|
57,465
|
|
|
$
|
58,642
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| XPERI CORPORATION |
| RECONCILIATION FROM GAAP TO NON-GAAP OPERATING EXPENSES |
| (in thousands) |
| (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
September 30, |
|
|
|
|
2018 |
|
2017 |
|
GAAP operating expenses
|
|
$
|
92,126
|
|
|
$
|
98,434
|
|
|
Adjustments to non-GAAP operating expenses:
|
|
|
|
|
|
Stock-based compensation --R&D
|
|
|
(3,252
|
)
|
|
|
(3,290
|
)
|
|
Stock-based compensation --SG&A
|
|
|
(4,201
|
)
|
|
|
(5,086
|
)
|
|
Amortization expense
|
|
|
(27,208
|
)
|
|
|
(27,769
|
)
|
|
Acquisition & related expense--R&D
|
|
|
—
|
|
|
|
(838
|
)
|
|
Acquisition & related expense--SG&A
|
|
|
—
|
|
|
|
(2,809
|
)
|
|
Non-GAAP operating expenses
|
|
$
|
57,465
|
|
|
$
|
58,642
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| XPERI CORPORATION |
| RECONCILIATION FROM GAAP TO NON-GAAP OTHER INCOME/(EXPENSE) |
| (in thousands) |
| (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
September 30, |
|
|
|
|
2018 |
|
2017 |
|
GAAP other income/(expense)
|
|
$
|
1,737
|
|
|
$
|
739
|
|
|
Adjustments to non-GAAP other income/(expense):
|
|
|
|
|
|
Interest income from significant financing components under Topic 606
|
|
|
(1,577
|
)
|
|
|
—
|
|
|
Non-GAAP other income/(expense)
|
|
$
|
160
|
|
|
$
|
739
|
|
|
|
|
|
|
|
|
|
|
|
|
| XPERI CORPORATION |
| RECONCILIATION FOR GUIDANCE ON |
| GAAP TO NON-GAAP OPERATING EXPENSE |
| (in millions) |
| (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
Year ended |
|
|
December 31, 2018 |
|
December 31, 2018 |
|
|
Low |
|
High |
|
Low |
|
High |
|
GAAP expense
|
|
$
|
95
|
|
|
$
|
99
|
|
|
$
|
377
|
|
|
$
|
381
|
|
|
Stock-based compensation--R&D
|
|
|
(4
|
)
|
|
|
(4
|
)
|
|
|
(14
|
)
|
|
|
(14
|
)
|
|
Stock-based compensation--SG&A
|
|
|
(5
|
)
|
|
|
(5
|
)
|
|
|
(17
|
)
|
|
|
(17
|
)
|
|
Acquisition & related expense
|
|
|
—
|
|
|
|
—
|
|
|
|
(3
|
)
|
|
|
(3
|
)
|
|
Amortization expense
|
|
|
(27
|
)
|
|
|
(27
|
)
|
|
|
(108
|
)
|
|
|
(108
|
)
|
|
Total of non-GAAP adjustments
|
|
|
(36
|
)
|
|
|
(36
|
)
|
|
|
(142
|
)
|
|
|
(142
|
)
|
|
Non-GAAP expense
|
|
$
|
59
|
|
|
$
|
63
|
|
|
$
|
235
|
|
|
$
|
239
|
|

View source version on businesswire.com: https://www.businesswire.com/news/home/20181107005811/en/
Source: Xperi Corporation
Xperi PR:
Jordan Miller, +1 818-436-1082
jordan.miller@xperi.com
or
Xperi
Investor Relations:
Geri Weinfeld, +1 818-436-1231
geri.weinfeld@xperi.com